R. Loch Macdonald, Chief Scientific Officer at Edge Therapeutics, Inc. (EDGE), sold 10,000 shares at $16.47 ($165K) on 2018-03-20, disclosed to the SEC on 2018-03-21.
Open-market sale of $165k EDGE by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.66 | 2,500 | $42K | 25.2% |
| 2 | $16.47 | 5,000 | $82K | 49.8% |
| 3 | $16.52 | 2,500 | $41K | 25.0% |
| Total | $16.53 avg | 10,000 | $165K | 100% |
| Filing → |